elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q24801524-3BE53FB5-0528-40CD-B518-CD181586C04C
Q24801524-3BE53FB5-0528-40CD-B518-CD181586C04C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24801524-3BE53FB5-0528-40CD-B518-CD181586C04C
The potential savings of using thiazides as the first choice antihypertensive drug: cost-minimisation analysis
P2860
Q24801524-3BE53FB5-0528-40CD-B518-CD181586C04C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24801524-3BE53FB5-0528-40CD-B518-CD181586C04C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
723e8426c32be151500940545127ef59131252ac
P2860
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)